Clinical and Biochemical Improvement After Switching From Agalsidase Alfa to Beta in a Boy With Classic Fabry Disease: A Case Report.

Saved in:
Bibliographic Details
Title: Clinical and Biochemical Improvement After Switching From Agalsidase Alfa to Beta in a Boy With Classic Fabry Disease: A Case Report.
Authors: Koga, Nobuhiko1 (AUTHOR), Yodogawa, Hiroaki1 (AUTHOR), Sawada, Takaaki2,3 (AUTHOR), Mushimoto, Yuichi4 (AUTHOR), Nagamitsu, Shinichiro1 (AUTHOR), Nakamura, Kimitoshi2,3 (AUTHOR), Hirose, Shinichi5 (AUTHOR), Inoue, Takahito1,6 (AUTHOR) inouet@fukuoka‐u.ac.jp
Source: Clinical Case Reports. Aug2026, Vol. 14 Issue 8, p1-5. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20500904
DOI:10.1002/ccr3.73353